Searchable abstracts of presentations at key conferences in endocrinology

ea0021p312 | Reproduction | SFEBES2009

Clinical experience of Nebido: monitoring the efficacy and safety of testosterone undecanoate in men over 60 years of age

Mantripp Diana , Smith Rachel , Karavitaki Niki , Wass John

Aim: In normal men testosterone levels fall with age. We wished to assess the efficacy and safety of Nebido in men over the age of 60 years in order to assess dose frequency and other potential complications.Subjects and methods: Ten men over 60 years of age (range 60–77 median 64) with primary or secondary hypogonadism were treated with Nebido 1000 mg i.m. Each was given a loading dose of two injections 6 weeks apart (our normal protocol for all pa...

ea0021p365 | Steroids | SFEBES2009

Chronic glucocorticoid treatment causes de novo methylation of Tpit and causes continued reduction in POMC expression after glucocorticoid withdrawal

Munir Alia , Powell Rachel , Eltobgi Adim , Newell-Price John

Introduction: Long-term repression of the HPA axis is a major side effect of chronic glucocorticoid administration, even after attempted withdrawal of therapy, and complicates management in patients. We have previously shown that the effect of chronic glucocorticoid treatment in vitro is in part mediated by inhibition of expression the POMC transcription factors Neuro D1 and Tpit, and that this is sustained on treatment withdrawal. We have now furth...

ea0020p45 | Adrenal | ECE2009

Long-term follow-up of a 46XX patient with congenital lipoid adrenal hyperplasia due to a new mutation of the steroidogenic acute regulatory protein gene

Albarel Frederique , Simonin Gilbert , Morel Yves , Brue Thierry , Reynaud Rachel

Congenital lipoid adrenal hyperplasia (CLAH) is a severe disorder characterized by early impairment of both adrenal and gonadal steroidogenesis, leading to early adrenal failure and male sex reversal. The most common aetiology of CLAH is mutation of Steroidogenic acute regulatory protein (StAR) gene.Objective: We report evolution over 20 years of a 46XX patient harbouring a novel StAR gene mutation.Methods: Clinical, hormonal and i...

ea0013p331 | Thyroid | SFEBES2007

Hypoxia inducible factor (HIF-1α) in thyroid carcinoma cell lines

Cowen Rachel , Williams Kaye , West Catherine , Resch Julia , Brabant Georg

Background: Tissue hypoxia is a hallmark of rapidly proliferating tumours which most frequently adapt and prosper under low oxygen tension. The transcription factor, HIF-1α, is mediating these effects and induces target genes involved in survival, invasion and resistance to drugs and radiation. No data are available on the functional regulation of HIF-1α in thyroid carcinoma cells.Methods: Using thyroid carcinoma cells derived from papillary (N...

ea0073aep242 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Post hip-fracture rehabilitation outcomes of diabetic and non-diabetic elderly patients

Ben-Joseph Ronen , luboshitz Barak , Heffez-Ayzenfeld Rachel , Twito Orit

BackgroundAlthough patients with diabetes mellitus (DM) are at higher risk of hip fracture, data regarding the effect of DM on rehabilitation outcomes is limited.MethodsA retrospective population-based study was conducted comparing diabetic and non-diabetic elderly patients with a recent hip fracture who were admitted to a geriatric rehabilitation facility during 2014–2019. The Functional Independence Me...

ea0074oc9 | Oral Communications | SFENCC2021

Cardiac arrhythmia and ischaemic stroke in a young man with Resistance to Thyroid Hormone beta

Hannon Anne Marie , Kinsella Justin , Crowley Rachel , Moran Carla

Case history: A 42 year old male teacher presented to the emergency department with an acute right MCA infarct, on a background of paroxysmal atrial fibrillation/flutter and recurrent supraventricular tachycardia. He had chronic palpitations, with previous failed cardiac ablation. He had no other medical history, specifically, no history of ear infections or learning difficulties. There was no known family history of thyroid dysfunction. Previous TSH levels (no FT4 measurement...

ea0094p41 | Bone and Calcium | SFEBES2023

Tumour-to-tumour metastasis to the parathyroid causing dual pathology hypercalcaemia

Sankar Adhithya , Brindle Rachel , Tymms James , O'Connell Ian , Kumar Mohit

An 85-year-old woman attended the endocrine clinic with hypercalcaemia and raised PTH levels. Her background included breast cancer treated with bilateral mastectomy and hormone therapy 3 years previously, with no evidence of disease on imaging 2 years previously. On attendance, her clinical examination was unremarkable, with no palpable neck mass. Biochemical investigations showed: Adj Ca 3.12 mmol/l, PTH 45.0 pmol/l, PO4 0.94 mmol/l, ALP 119U/l, Alb 45g/l, 25-OH Vit D 15.7 n...

ea0094p185 | Bone and Calcium | SFEBES2023

A retrospective audit of patients with fragility hip or vertebral fracture - assessing suitability for romosozumab

Batten Lucy , Melrose Rachel , Narayanan Deepa , Aye Mo

Introduction: The current UK guidelines (NICE TA791) recommend the use of romosozumab, a monoclonal sclerostin inhibitor, for patients at high imminent risk of fragility fractures. However, elderly patients with a very high risk of fractures often exhibit frailty and other comorbidities. This retrospective survey was conducted in a major trauma centre in northern England to evaluate the potential utilisation of romosozumab in a real-world setting.<p class=...

ea0095p102 | Diabetes 3 | BSPED2023

Prohormone convertase 1/3 deficiency can be associated with diabetes mellitus in childhood

Varughese Rachel , Howard Sasha , Butler Gary , Dattani Mehul

Prohormone convertase 1/3 (PC1/3) deficiency is rare, caused by homozygous or compound heterozygous mutations in the PCSK1 gene. PCSK1 encodes a serine protease important in cleavage of several proneuropeptides and prohormones. Despite a variety of known endocrine associations, paediatric diabetes mellitus is rare, described only once before. Previous understanding was that biological activity of elevated proinsulin (<5% of the activity of insulin) confers protection from ...

ea0037gp.04.03 | Steroids | ECE2015

Using a morning cortisol to predict adrenal reserve and guide management

Woods Conor , Argese Nicola , Chapman Matthew , Webster Rachel , Toogood Andrew , Arlt Wiebke , Stewart Paul , Crowley Rachel , Tomlinson Jeremy

Background: The short Synacthen test (SST) is the most widely used dynamic assessment of adrenal reserve. In some situations, the SST may be difficult to perform. Random basal cortisol levels could provide an alternative screening assessment to rationalize which patients need dynamic testing. This is highly clinically relevant, given the large numbers of patients taking prescribed glucocorticoids who are at risk of iatrogenic adrenal suppression.Methods:...